Beasley R, Smith K, Pearce N, Crane J, Burgess C, Culling C
Department of Medicine, Wellington School of Medicine, New Zealand.
Med J Aust. 1990 Jun 4;152(11):570, 572-3. doi: 10.5694/j.1326-5377.1990.tb125385.x.
Trends in mortality from asthma in non-Maori New Zealanders aged 5 to 34 years were examined for the period 1908-1986. Two previously documented epidemics of death from asthma occurred in the 1960s and the late 1970s. These epidemics are most likely to have been due to changes in the management of asthma: the introduction of isoprenaline forte by metered dose inhaler in the 1960s and inhaled fenoterol in the 1970s. A previously unreported rise in mortality, which was more gradual in onset and less severe, occurred in the 1940s and 1950s; a similar pattern occurred in England and Wales during the same period. It is unlikely that this increase in mortality was solely due to changes in diagnostic fashion or disease coding. Possible explanations include changes in the management or prevalence of asthma, or in environmental factors. It is notable that mortality was below 0.5 per 100,000 person-years prior to 1940, but has subsequently increased considerably. Thus, while modern methods for treating asthma have improved the quality of life of many asthmatics, mortality has increased during the period of their introduction and use.
对1908年至1986年期间5至34岁的非毛利族新西兰人的哮喘死亡率趋势进行了研究。之前记录的两次哮喘死亡流行分别发生在20世纪60年代和70年代末。这些流行很可能是由于哮喘治疗管理的变化:20世纪60年代通过定量吸入器引入了异丙肾上腺素强力剂,70年代引入了吸入用非诺特罗。20世纪40年代和50年代出现了此前未报告的死亡率上升,其起病较为缓慢且严重程度较低;同期英格兰和威尔士也出现了类似模式。这种死亡率的增加不太可能仅仅是由于诊断方式或疾病编码的变化。可能的解释包括哮喘治疗管理或患病率的变化,或环境因素的变化。值得注意的是,1940年之前死亡率低于每10万人年0.5,但随后大幅上升。因此,虽然现代哮喘治疗方法改善了许多哮喘患者的生活质量,但在引入和使用这些方法期间死亡率却有所上升。